There were significantly (p < 0.01) high p53 gene serum levels in patients with CML (2.135 ± 1.44 ng/mL) compared to the control (0.142 ± 0.11 ng/mL). This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.